These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Sensitivity of multidrug-resistant MCF-7 cells to a transferrin-doxorubicin conjugate.
    Author: Lemieux P, Pagé M.
    Journal: Anticancer Res; 1994; 14(2A):397-403. PubMed ID: 8017839.
    Abstract:
    Two multidrug-resistant breast cancer cell lines (MCF-7/AdrVp and MCF-7/D.40) each expressing a different membrane protein, involved in the drug resistance, have been treated with a transferrin-doxorubicin conjugate. Conjugates have shown an increase of activity over free doxorubicin on these resistant cell lines. Growth inhibition of doxorubicin-resistant cells, as evaluated by the MTT-assay, was higher for conjugates than for free doxorubicin especially for a 4-day contact period. I D 50 were twice and 10-fold lower for the conjugate than for free doxorubicin on resistant cells. MCF-7/AdrVp seemed to be particularly affected by the conjugate even if its intracellular content of doxorubicin was similar. With the Trf-Dox conjugate, an inverted correlation does exist between the drug-DNA content and the cytotoxicity of the conjugate. Verapamil influenced the uptake of free doxorubicin but not the uptake of Trf-Dox conjugate, thus showing a different mechanism of entry.
    [Abstract] [Full Text] [Related] [New Search]